Browse > Article
http://dx.doi.org/10.15616/BSL.2020.26.2.120

Comparison of Fluoroquinolone Resistance Determinants in Uropathogenic Escherichia coli between 2 Time Periods of 1989 and 2010-2014 at Gangwon Province in Korea  

Park, Min (Department of Biomedical Laboratory Science, Daekyeung University)
Publication Information
Biomedical Science Letters / v.26, no.2, 2020 , pp. 120-126 More about this Journal
Abstract
Fluoroquinolone (FQ) resistant uropathogenic Escherichia coli (UPEC) have become a major problem in urinary tract infections (UTIs). The purpose of this study was to compare the quinolone resistance-determining region (QRDR) and plasmid mediated quinolone resistance (PMQR) determinants of FQ resistant UPEC between 1989 and 2010-2014. A total of 681 strains of UPEC clinical isolates was collected from Korean healthcare facility in 1989 (123 strains) and in 2010-2014 (558 strains). The minimum inhibitory concentrations (MICs) of FQs were determined by agar dilution method. QRDRs (gyrA, gyrB, parC and parE) and PMQR determinants (qnrA, qnrB, qnrS, aac(6')-Ib-cr and qepA) were analyzed polymerase chain reaction and sequencing method. Among 681 isolates, FQ resistant UPEC were 3 strains (2.4%) in 1989 isolates and 220 strains (39.4%) in 2010-2014 isolates. The rate of the FQ resistant UPEC strains in 2010-2014 isolates was increased than that of in 1989 isolates. UPEC isolates from 1989 and 2010-2014 were shown to carry mutations in gyrA (Ser83 and Asp87), gyrB (Ser464 and Thr469), parC (Ser80 and Glu84) and parE (Glu460, Ser458, Ile464 and Leu445). The most common mutations of QRDRs in 1989 isolates were Ser83Leu and Asp87Gly in gyrA and Ser80Ile in parC (2 strains: 66.7%) while those in 2010-2014 isolates were Ser83Leu and Asp87Asn in gyrA and Ser80Il2 and Glu84Val in parC (88 strains: 40.0%). PMQR determinants were detected only in 2010-2014 UPEC strains (47 strains: 21.4%).
Keywords
Uropathogenic Escherichia coli (UPEC); Quinolone-determining regions (QRDRs); Plasmid-mediated quinolone resistance determinants (PMQRs);
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Fihman V, Lartigue MF, Jacquier H, Meunier F, Schnepf N, Raskine L, Riahi J, Sanson-le Pors MJ, Bercot B. Appearance of aac(6')-Ib-cr gene among extended-spectrum beta-lactamaseproducing Enterobacteriaceae in a French hospital. J Infect. 2008. 56: 454-459.   DOI
2 Kang CI, Kim JE, Park DW, Kim BN, Ha US, Lee SJ, Yeo JK, Min SK, Lee HY, Wie SH. Clinical Practice Guidelines for the Antibiotic Treatment of Community-Acquired Urinary Tract Infections. Infect Chemother. 2018. 50: 67-100.   DOI
3 Li D, Liu B, Guo X, Liu F, Feng L, Wang L. A multiplex PCR method to detect 14 Escherichia coli serogroups associated with urinary tract infections. J Microbiol Methods. 2010. 82: 71-77.   DOI
4 Liu X, Boothe DM, Thungrat K, Aly S. Mechanisms accounting for fluoroquinolone multidrug resistance Escherichia coli isolated from companion animals. Vet Microbiol. 2012. 28; 161: 159-168.   DOI
5 Liu CS, Yoon EJ, Kim DK, Shin JH, Shin JH, Shin KS, Kim YA, Uh Y, Kim HS, Kim YR, Jeong SH. Antimicrobial resistance in South Korea: A report from the Korean global antimicrobial resistance surveillance system (Kor-GLASS) for 2017. J Infect Chemother. 2019. 25: 845-859.   DOI
6 Le TM, Baker S, Le TP, Le TP, Cao TT, Tran TT, Nguyen VM, Campbell JI, Lam MY, Nguyen TH, Nguyen VV, Farrar J, Schultsz C. High prevalence of plasmid-mediated quinolone resistance determinants in commensal members of the Enterobacteriaceae in Ho Chi Minh City, Vietnam. J Med Microbiol. 2009. 58: 1585-1592.   DOI
7 Lee SJ, Cho YH, Kim BW, Lee JG, Jung SI, Lee SD, Lee SE, Kim ME, Choi YD, Rim JS, Sim BS, Cho IR, Ryu SB, Kim CS, Kim WJ, Lee TY. A Multicenter Study of Antimicrobial Susceptibility of Uropathogens Causing Acute Uncomplicated Cystitis in Woman. Korean J Urol. 2003. 44: 697-701.
8 Sung JY. Analysis of Quinolone Resistance Determinants in Escherichia coli Isolated from Clinical Specimens and Livestock Feces. Korean J Clin Lab Sci. 2018. 50: 422-430.   DOI
9 Takahashi A, Muratani T, Yasuda M, Takahashi S, Monden K, Ishikawa K, Kiyota H, Arakawa S, Matsumoto T, Shima H, Kurazono H, Yamamoto S. Genetic profiles of fluoroquinoloneresistant Escherichia coli isolates obtained from patients with cystitis: phylogeny, virulence factors, PAIusp subtypes, and mutation patterns. J Clin Microbiol. 2009. 47: 791-795.   DOI
10 Vila J, Ruiz J, Goni P, De Anta MT. Detection of Mutations in parC in Quinolone-Resistant Clinical Isolates of Escherichia coli. Antimicrob Agents Chemother. 1996. 40: 491-493.   DOI
11 Yang HS, Kim YJ, Cho SY, Nam YS, Oh TS, Park KS, Kim HC, Lee HJ. Fluoroquinolone Resistance Mechanisms by Molecular Epidemiologic Study of Ciprofloxacin-Nonsusceptible Escherichia coli Sequence Types Isolated from Clinical Specimens in a Tertiary Care University Hospital in Korea: Emergence of Clone ST131, 2006-2008. Ann Clin Lab Sci. 2017. 47: 511-515.
12 Patel J, Cockerill III F, Eliopoulos G, Jenkins S, Lewis II J, Limbago B, Nicolau D, Patel R, Powell M, Richter S, Swenson J, Traczewaki M, Turnidge J, Weinstein M, Zimmer B. Performance standards for antimicrobial susceptibility testing. 2016. 26th ed. pp. 52-60. Clinical Laboratory Standards Institute. Wayne, PA, USA.
13 Lee JH, Subhadra B, Son YJ, Kim DH, Park HS, Kim JM, Koo SH, Oh MH, Kim HJ, Choi CH. Phylogenetic group distributions, virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli strains isolated from patients with urinary tract infections in South Korea. Letters in Applied Microbiology. 2015. 62: 84-90.   DOI
14 Machuca J, Ortiz M, Recacha E, Diaz-De-Alba P, Docobo-Rerez F, Rodriguez-Martinez JM., Pascual A. Impact of AAC(6')-Ib-cr in combination with chromosomal-mediated mechanisms on clinical quinolone resistance in Escherichia coli. J Antimicrob Chemother. 2016. 71: 2066-3071.   DOI
15 Nakano R, Nakano A, Abe M, Nagano N, Ashara M, Furukawa T, Ono Y, Yano H, Okamoto R. Prevalence and mechanism of fluoroquinolone resistance in clinical isolates of Proteus mirabilis in Japan. Heliyon. 2019. 2; 5: e10291.
16 Rehman A, Patrick WM., Lamont IL. Mechanisms of Ciprofloxacin Resistance in Pseudomonas aeruginosa: New Approaches to an Old Problem. J Med Microbiol. 2019. 68: 1-10.   DOI
17 Song SW, Lee EY, Koh EM, Ha HS, Jeong HJ, Bae IK, Jeong SH. Antibiotic resistance mechanisms of Escherichia coli isolates from urinary specimens. Korean J Lab Med. 2009. 29: 17-24.   DOI
18 Chang IH, Bang SH, Choi NY, Park SY, Han JH, Ahn SH. Trends in the Emergence of Ciprofloxacin-resistant Escherichia coli and the Relationship with Underlying Diseases in Patients with Urinary Tract Infection. Korean J Urol. 2008. 49: 66-71.   DOI
19 Betitra Y, Teresa V, Miguel V, Abdelaziz T. Determinants of Quinolone Resistance in Escherichia coli Causing Community-Acquired Urinary Tract Infection in Bejaia, Algeria. Asian Pac J Trop Med. 2014. 7: 462-467.   DOI
20 Cattoir V, Poirel L, Rotimi V, Soussy CJ, Nordmann P. Multiplex PCR for detection of plasmid-mediated quinolonone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother. 2007. 60: 394-397.   DOI
21 Dehbanipour D, Khanahmad H, Sedighi M, Bialvaei AZ, Faghri J. High Prevalence of Fluoroquinolone-Resistant Escherichia coli Strains Isolated From Urine Clinical Samples. J Prev Med Hyg. 2019. 29; 60: E25-E30.